• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇化气体囊泡:一种用于肝脏肿瘤诊断及引导射频消融的新型超声造影剂,前景广阔。

PEGylated gas vesicles: a promising novel ultrasound contrast agent for diagnosis and guiding radiofrequency ablation of liver tumor.

作者信息

Yu Kezhi, Huang Yongquan, Wang Yuanyuan, Wu Qunyan, Wang Zihang, Li Fei, Chen Jianri, Yibulayin Maierhaba, Zhang Shushan, Su Zhongzhen, Yan Fei

机构信息

Department of Ultrasound, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, China.

Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, Guangdong Province, China.

出版信息

J Nanobiotechnology. 2025 May 14;23(1):344. doi: 10.1186/s12951-025-03377-z.

DOI:10.1186/s12951-025-03377-z
PMID:40369524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12076873/
Abstract

Ultrasound contrast agents (UCAs) play an important role in diagnosis and the imaging-guided treatment of liver tumor in clinical settings. However, most commercially available UCAs are micro-sized and fabricated through a chemical synthesis route. Here, we developed a new class of biosynthesized nanoscale contrast agent (PEG-GVs) and comprehensively compared its physicochemical characteristics and imaging performance with commercial Sonovue and Sonazoid. Our results revealed PEG-GVs may produce more stable and durable contrast signals, contributing to their penetration beyond blood vessels and long-time retention in liver. Interestingly, we found that PEG-GVs did not exhibit a continuously enhanced accumulation in the liver tumor due to the EPR effect, but displayed a rapid regression. The long-time retention of PEG-GVs in normal liver tissue and rapid regression from liver tumor lead to distinct display of liver tumor boundaries, enabling the early diagnosis of small liver metastases and presenting advantages in guiding radiofrequency ablation of liver tumor. Moreover, we have also verified that PEG-GVs exhibit excellent imaging performance and biosafety in macaques. Our study provides new insights into the roles of PEG-GVs in liver tumor diagnosis and ablation guidance.

摘要

超声造影剂(UCAs)在临床肝脏肿瘤的诊断及影像引导治疗中发挥着重要作用。然而,大多数市售的超声造影剂为微米级,通过化学合成路线制备。在此,我们开发了一类新型的生物合成纳米级造影剂(PEG-GVs),并将其理化特性和成像性能与市售的声诺维(Sonovue)和索拉迪德(Sonazoid)进行了全面比较。我们的结果表明,PEG-GVs可能产生更稳定、持久的造影信号,有助于其穿透血管并在肝脏中长期留存。有趣的是,我们发现PEG-GVs并未因增强渗透滞留(EPR)效应而在肝肿瘤中持续增强蓄积,而是呈现快速消退。PEG-GVs在正常肝组织中的长期留存以及从肝肿瘤中的快速消退导致肝肿瘤边界清晰显示,从而能够早期诊断小的肝转移灶,并在引导肝肿瘤射频消融方面具有优势。此外,我们还证实了PEG-GVs在猕猴中表现出优异的成像性能和生物安全性。我们的研究为PEG-GVs在肝肿瘤诊断和消融引导中的作用提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/2a7e0fd15eec/12951_2025_3377_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/ed1266d6ef7c/12951_2025_3377_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/36a1dd6bfed0/12951_2025_3377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/4f694aa0070e/12951_2025_3377_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/ee0efb57226d/12951_2025_3377_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/a6dc39496e27/12951_2025_3377_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/1fb968815454/12951_2025_3377_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/2a7e0fd15eec/12951_2025_3377_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/ed1266d6ef7c/12951_2025_3377_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/36a1dd6bfed0/12951_2025_3377_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/4f694aa0070e/12951_2025_3377_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/ee0efb57226d/12951_2025_3377_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/a6dc39496e27/12951_2025_3377_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/1fb968815454/12951_2025_3377_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/618f/12076873/2a7e0fd15eec/12951_2025_3377_Fig6_HTML.jpg

相似文献

1
PEGylated gas vesicles: a promising novel ultrasound contrast agent for diagnosis and guiding radiofrequency ablation of liver tumor.聚乙二醇化气体囊泡:一种用于肝脏肿瘤诊断及引导射频消融的新型超声造影剂,前景广阔。
J Nanobiotechnology. 2025 May 14;23(1):344. doi: 10.1186/s12951-025-03377-z.
2
A Comparative Study of SonoVue and Sonazoid for Contrast-Enhanced Ultrasound CT/MRI Fusion Guidance During Radiofrequency Ablation of Poorly Visualized Hepatic Malignancies: A Prospective Intra-Individual Analysis.超声造影剂声诺维与声振造影剂 SonoVue 用于增强超声 CT/MRI 融合引导射频消融治疗肝内乏血供肿瘤的前瞻性个体内对比研究。
Ultrasound Med Biol. 2024 Dec;50(12):1879-1884. doi: 10.1016/j.ultrasmedbio.2024.08.014. Epub 2024 Sep 20.
3
Ultrasound Molecular Imaging of Blood Vessel Walls and Vulnerable Plaques via CXCR4-Targeted Nanoscale GVs.通过靶向CXCR4的纳米级基因载体实现血管壁和易损斑块的超声分子成像
Int J Nanomedicine. 2025 May 16;20:6205-6220. doi: 10.2147/IJN.S504265. eCollection 2025.
4
Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid.肝脏超声造影成像: SonoVue 和 Sonazoid 的临床证据综述。
Abdom Radiol (NY). 2020 Nov;45(11):3779-3788. doi: 10.1007/s00261-020-02573-9.
5
Comparison of Sonazoid and SonoVue in the Diagnosis of Focal Liver Lesions: A Preliminary Study.声诺维与声诺美在肝脏局灶性病变诊断中的比较:一项初步研究。
J Ultrasound Med. 2019 Sep;38(9):2417-2425. doi: 10.1002/jum.14940. Epub 2019 Jan 25.
6
Tumor Contrast Imaging with Gas Vesicles by Circumventing the Reticuloendothelial System.气体囊泡绕过网状内皮系统的肿瘤对比成像。
Ultrasound Med Biol. 2020 Feb;46(2):359-368. doi: 10.1016/j.ultrasmedbio.2019.09.009. Epub 2019 Nov 8.
7
Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.评估肝细胞癌的动脉期增强和晚期廓清: SonoVue® 和 Sonazoid® 超声造影的荟萃分析。
Eur Radiol. 2024 Jun;34(6):3795-3812. doi: 10.1007/s00330-023-10371-2. Epub 2023 Nov 22.
8
Surface-modified GVs as nanosized contrast agents for molecular ultrasound imaging of tumor.表面修饰的气体微泡作为用于肿瘤分子超声成像的纳米级造影剂。
Biomaterials. 2020 Apr;236:119803. doi: 10.1016/j.biomaterials.2020.119803. Epub 2020 Jan 28.
9
Prospective assessment of diagnostic efficacy and safety of Sonazoid and SonoVue ultrasound contrast agents in patients with focal liver lesions.前瞻性评估 SonoVue 和 Sonazoid 超声造影剂在局灶性肝脏病变患者中的诊断效能和安全性。
Abdom Radiol (NY). 2021 Oct;46(10):4647-4659. doi: 10.1007/s00261-021-03010-1. Epub 2021 Jun 16.
10
Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents.针头和导管尺寸对市售超声造影剂的影响。
J Ultrasound Med. 2015 Nov;34(11):1961-8. doi: 10.7863/ultra.14.11008. Epub 2015 Sep 18.

本文引用的文献

1
Differentiating atypical hepatocellular carcinoma from focal nodular Hyperplasia: The value of Kupffer phase imaging with Sonazoid-Contrast-Enhanced ultrasound compared to Gadodiamide-Enhanced MRI.鉴别非典型肝细胞癌与局灶性结节性增生:与钆双胺增强MRI相比,使用声诺维增强超声进行库普弗期成像的价值
Eur J Radiol. 2025 Mar;184:111991. doi: 10.1016/j.ejrad.2025.111991. Epub 2025 Feb 7.
2
Ultrasound-triggered drug-loaded nanobubbles for enhanced T cell recruitment in cancer chemoimmunotherapy.用于癌症化学免疫治疗中增强T细胞募集的超声触发载药纳米气泡
Biomaterials. 2025 Jun;317:123086. doi: 10.1016/j.biomaterials.2025.123086. Epub 2025 Jan 2.
3
First clinical utility of sensing Ultrasound Localization Microscopy (sULM): identifying renal pseudotumors.
超声定位显微镜检查(sULM)的首次临床应用:识别肾假瘤。
Theranostics. 2025 Jan 1;15(1):233-244. doi: 10.7150/thno.100897. eCollection 2025.
4
Assessing Therapeutic Nanoparticle Accumulation in Tumors Using Nanobubble-Based Contrast-Enhanced Ultrasound Imaging.使用基于纳米气泡的对比增强超声成像评估治疗性纳米颗粒在肿瘤中的蓄积情况。
ACS Nano. 2024 Dec 3;18(48):33181-33196. doi: 10.1021/acsnano.4c11805. Epub 2024 Nov 20.
5
Perfluorobutane-Enhanced CEUS in Intrahepatic Cholangiocarcinoma: Correlating Imaging Features With Liver Backgrounds and Tumor Sizes.经氟丁烷增强的超声造影在肝内胆管细胞癌中的应用:与肝背景和肿瘤大小的影像特征相关。
Ultrasound Med Biol. 2025 Jan;51(1):70-76. doi: 10.1016/j.ultrasmedbio.2024.09.009. Epub 2024 Oct 18.
6
Truly Tiny Acoustic Biomolecules for Ultrasound Imaging and Therapy.用于超声成像和治疗的真正微小声学生物分子。
Adv Mater. 2024 Jul;36(28):e2307106. doi: 10.1002/adma.202307106. Epub 2024 Mar 15.
7
Prospects and hazards of silica nanoparticles: Biological impacts and implicated mechanisms.硅纳米粒子的前景与危害:生物学影响及潜在机制。
Biotechnol Adv. 2023 Dec;69:108277. doi: 10.1016/j.biotechadv.2023.108277. Epub 2023 Nov 3.
8
Ultrasound Molecular Imaging of Bladder Cancer via Extradomain B Fibronectin-Targeted Biosynthetic GVs.通过外显结构域 B 纤连蛋白靶向生物合成 GV 对膀胱癌进行超声分子成像。
Int J Nanomedicine. 2023 Aug 29;18:4871-4884. doi: 10.2147/IJN.S412422. eCollection 2023.
9
Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.超声造影联合六氟化硫微泡和全氟丁烷微泡:LI-RADS 用于诊断肝细胞癌。
Radiology. 2023 Aug;308(2):e230150. doi: 10.1148/radiol.230150.
10
Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline.用于肝细胞癌无创成像诊断的声诺维增强超声检查:特别强调2022年KLCA-NCC指南
Ultrasonography. 2023 Oct;42(4):479-489. doi: 10.14366/usg.23051. Epub 2023 Jun 15.